Agencies and Commissions March 4, 2020 – Federal Register Recent Federal Regulation Documents

Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (``ID'') (Order No. 20) of the presiding administrative law judge (``ALJ'') granting the parties' joint motion to terminate the investigation in its entirety based on a settlement agreement.

The U.S. Nuclear Regulatory Commission (NRC) has determined that renewal of the charter for the Advisory Committee on the Medical Uses of Isotopes (ACMUI) until February 28, 2022, is in the public interest in connection with duties imposed on the Commission by law. This action is being taken in accordance with the Federal Advisory Committee Act, after consultation with the Committee Management Secretariat, General Services Administration. The purpose of the ACMUI is to provide advice to the NRC on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy. Responsibilities include providing guidance and comments on current and proposed NRC regulations and regulatory guidance concerning medical use; evaluating certain non- routine uses of byproduct material for medical use; and evaluating training and experience of proposed authorized users. The members are involved in preliminary discussions of major issues in determining the need for changes in NRC policy and regulation to ensure the continued safe use of byproduct material. Each member provides technical assistance in his/her specific area(s) of expertise, particularly with respect to emerging technologies. Members also provide guidance as to NRC's role in relation to the responsibilities of other Federal agencies as well as of various professional organizations and boards. Members of this Committee have demonstrated professional qualifications and expertise in both scientific and non-scientific disciplines including nuclear medicine; nuclear cardiology; radiation therapy; medical physics; nuclear pharmacy; State medical regulation; patient's rights and care; health care administration; and Food and Drug Administration regulation.

In this document, as part of the Commission's effort to manage its dockets and reduce backlog and in an effort to avoid the need to address issues unnecessarily, the Wireline Competition Bureau (Bureau) seeks to determine parties' continuing interest in eight pending petitions for reconsideration of various aspects of the intercarrier compensation provisions of the USF/ICC Transformation Order. The Bureau therefore plans to dismiss each Petition listed below with prejudice unless a Petitioner files a notice in the relevant dockets within 45 days of the date of Federal Register publication of this Public Notice specifying that it objects to the dismissal of its Petition.

The Copyright Royalty Judges publish a final rule governing the rates and terms for the digital performance of sound recordings by noncommercial educational webcasters and for the making of ephemeral recordings necessary for the facilitation of such transmissions for the period commencing January 1, 2021, and ending on December 31, 2025.